Measuring the Benefits of Healthcare: DALYs and QALYs - Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions

被引:34
作者
Augustovski, Federico [1 ]
Colantonio, Lisandro D. [2 ]
Galante, Julieta [3 ]
Bardach, Ariel [1 ]
Caporale, Joaquin E. [1 ]
Zarate, Victor [4 ]
Chuang, Ling Hsiang [5 ]
Riviere, Andres Pichon [1 ]
Kind, Paul [6 ]
机构
[1] Inst Clin Effectiveness & Hlth Policy IEC CONICET, Buenos Aires, DF, Argentina
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Cardiff Univ, Cardiff, S Glam, Wales
[4] Univ San Sebastian, Fac Med, Santiago, Chile
[5] Pharmerit, Rotterdam, Netherlands
[6] Univ Leeds, Leeds, W Yorkshire, England
关键词
Quality-Adjusted Life Year (QALY); Disability-Adjusted Life Year (DALY); Health Benefit Measure; Economic Evaluation; ADJUSTED LIFE YEARS; VALUATION; DISEASES; WEIGHTS; STATES;
D O I
10.15171/ijhpm.2017.47
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The measurement of health benefits is a key issue in health economic evaluations. There is very scarce empirical literature exploring the differences of using quality-adjusted life years (QALYs) or disability-adjusted life years (DALYs) as benefit metrics and their potential impact in decision-making. Methods: Two previously published models delivering outputs in QALYs, were adapted to estimate DALYs: a Markov model for human papilloma virus (HPV) vaccination, and a pneumococcal vaccination deterministic model (PNEUMO). Argentina, Chile, and the United Kingdom studies were used, where local EQ-5D social value weights were available to provide local QALY weights. A primary study with descriptive vignettes was done (n = 73) to obtain EQ-5D data for all health states included in both models. Several scenario analyses were carried-out to evaluate the relative importance of using different metrics (DALYS or QALYs) to estimate health benefits on these economic evaluations. Results: QALY gains were larger than DALYs avoided in all countries for HPV, leading to more favorable decisions using the former. With discounting and age-weighting -scenario with greatest differences in all countries - incremental DALYs avoided represented the 75%, 68%, and 43% of the QALYs gained in Argentina, Chile, and United Kingdom respectively. Differences using QALYs or DALYs were less consistent and sometimes in the opposite direction for PNEUMO. These differences, similar to other widely used assumptions, could directly influence decision-making using usual gross domestic products (GDPs) per capita per DALY or QALY thresholds. Conclusion: We did not find evidence that contradicts current practice of many researchers and decision-makers of using QALYs or DALYs interchangeably. Differences attributed to the choice of metric could influence final decisions, but similarly to other frequently used assumptions.
引用
收藏
页码:120 / 136
页数:17
相关论文
共 29 条
[1]   ADJUSTING LIFE FOR QUALITY OR DISABILITY: STYLISTIC DIFFERENCE OR SUBSTANTIAL DISPUTE? [J].
Airoldi, Mara ;
Morton, Alec .
HEALTH ECONOMICS, 2009, 18 (11) :1237-1247
[2]  
[Anonymous], 2006, 1 ENC NAC FACT RIESG
[3]  
[Anonymous], PRINC GLOB IND
[4]   Argentine Valuation of the EQ-5D Health States [J].
Ariel Augustovski, Federico ;
Edit Irazola, Vilma ;
Pascual Velazquez, Alberto ;
Gibbons, Luz ;
Craig, Benjamin M. .
VALUE IN HEALTH, 2009, 12 (04) :587-596
[5]   The value of DALY life: problems with ethics and validity of disability adjusted life years [J].
Arnesen, T ;
Nord, E .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 319 (7222) :1423-1425
[6]   Can the value choices in DALYs influence global priority-setting? [J].
Arnesen, T ;
Kapiriri, L .
HEALTH POLICY, 2004, 70 (02) :137-149
[7]  
Augustovski F, 2010, EXPERT REV PHARM OUT, V10, P525, DOI [10.1586/erp.10.56, 10.1586/ERP.10.56]
[8]   Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 [J].
Briggs, Andrew H. ;
Weinstein, Milton C. ;
Fenwick, Elisabeth A. L. ;
Karnon, Jonathan ;
Sculpher, Mark J. ;
Paltiel, A. David .
VALUE IN HEALTH, 2012, 15 (06) :835-842
[9]   Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries [J].
Colantonio, Lisandro ;
Gomez, Jorge A. ;
Demarteau, Nadia ;
Standaert, Baudouin ;
Pichon-Riviere, Andres ;
Augustovski, Federico .
VACCINE, 2009, 27 (40) :5519-5529
[10]   Modeling the Impact of a New Vaccine on Pneumococcal and Nontypable Haemophilus influenzae Diseases: A New Simulation Model [J].
De Wals, Philippe ;
Black, Steven ;
Borrow, Ray ;
Pearce, David .
CLINICAL THERAPEUTICS, 2009, 31 (10) :2152-2169